These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8103125)

  • 1. [Application of image analysis and flow cytometry for lung cancer cytology].
    Konaka C; Kato H; Ikeda N; Shimizu E; Kamura T
    Rinsho Byori; 1993 Jun; Suppl 94():66-75. PubMed ID: 8103125
    [No Abstract]   [Full Text] [Related]  

  • 2. [PCNA (proliferating cell nuclear antigen) expression in adenocarcinomas < 2 cm of the peripheral lung].
    Koshikawa T; Nakamura S; Kitoh K; Hayashi K; Suyama M; Kunishima K
    Rinsho Byori; 1993 Jun; Suppl 94():113-24. PubMed ID: 8103122
    [No Abstract]   [Full Text] [Related]  

  • 3. [Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA)].
    Ichikawa A; Shimamura K; Koyama Y
    Nihon Rinsho; 1992 Oct; 50(10):2343-8. PubMed ID: 1360029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoperoxidase detection of cell proliferation markers: confirmation of the specificity and its application to cytology].
    Hori S; Tsutsumi Y
    Rinsho Byori; 1993 Jun; Suppl 94():161-74. PubMed ID: 8103123
    [No Abstract]   [Full Text] [Related]  

  • 5. [Flow & image cytometry and clinical applications in cancer diagnosis].
    Nishiya I; Izutsu T
    Rinsho Byori; 1993 Jun; Suppl 94():51-65. PubMed ID: 8361009
    [No Abstract]   [Full Text] [Related]  

  • 6. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M; Elsner B; Paez De Lima A; Esteva H; Marchevsky AM
    Mod Pathol; 1997 Dec; 10(12):1221-7. PubMed ID: 9436967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of proliferative index in squamous cell carcinoma by flow cytometry.
    Ferguson PJ; Garland A; Lampe HB
    J Otolaryngol; 1992 Oct; 21(5):331-8. PubMed ID: 1361586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.
    Ishikuro A; Dosaka-Akita H; Kato M; Fujino M; Isobe H; Miyamoto H; Inoue K; Kawakami Y
    Cytometry; 1997 Aug; 30(4):186-91. PubMed ID: 9298837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of AgNORs in lung cancer].
    Abe S
    Rinsho Byori; 1993 Jun; Suppl 94():104-12. PubMed ID: 8361003
    [No Abstract]   [Full Text] [Related]  

  • 12. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
    Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
    Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DNA content analysis and detection of c-myc and p53 products using flow cytometry in resected lung cancer cases].
    Chiba W; Sawai S; Ikeda S; Morimoto K; Wazawa H; Hanawa T; Yamashita N; Matsui T; Hatakenaka R; Matsubara Y
    Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():108-16. PubMed ID: 8203922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cavitation of squamous carcinoma of the lung.
    Lavoie RR; McDonald JR; Kling GA
    Acta Cytol; 1977; 21(2):210-4. PubMed ID: 266330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
    Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
    Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer.
    Carey FA; Gray E; O'Mahony M; Craig SR; Salto-Tellez M; Lamb D
    Anal Cell Pathol; 1996 Dec; 12(3):137-43. PubMed ID: 9025990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The diagnostic value of flow cytometric DNA analysis of bronchial washing and lavage fluids in lung cancer].
    Tao M; Li J; Wu J
    Zhonghua Jie He He Hu Xi Za Zhi; 1996 Aug; 19(4):222-5. PubMed ID: 9596829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
    Golouh R; Bracko M; Novak J
    Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.